Winton Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,357
Closed -$126K 716
2024
Q3
$126K Sell
21,357
-29,666
-58% -$197K 0.01% 588
2024
Q2
$354K Buy
+51,023
New +$359K 0.02% 464
2024
Q1
Sell
-23,944
Closed -$210K 771
2023
Q4
$210K Sell
23,944
-1,760
-7% -$12.9K 0.02% 631
2023
Q3
$187K Buy
+25,704
New +$191K 0.02% 673

Other funds holding MDXG

Winton Group's MDXG Position: Q4 2024 in Review

Winton Group sold out of MiMedx Group (MDXG) in Q4 2024, closing a stake of 21,357 shares — an estimated $126K sold.

Winton Group first reported a position in MDXG in Q3 2023 and held it in 4 quarters. The position peaked at $354K in Q2 2024. 213 funds tracked by Wall St. Rank hold MDXG as of Q4 2024.

  • Winton Group reported no remaining MiMedx Group position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 21,357 MiMedx Group shares in Q4 2024, an estimated $126K.
  • Winton Group first reported a position in MiMedx Group in Q3 2023 and held it in 4 quarters.
  • Winton Group's MiMedx Group position peaked at $354K in Q2 2024.
  • 213 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.